Adherex Technologies (FENC)
(Delayed Data from NSDQ)
$7.84 USD
-0.34 (-4.16%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $7.88 +0.04 (0.51%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
FENC 7.84 -0.34(-4.16%)
Will FENC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FENC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FENC
Are Medical Stocks Lagging Editas Medicine (EDIT) This Year?
Recent Price Trend in Adherex Technologies (FENC) is Your Friend, Here's Why
FENC: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Joint Misses Q1 Earnings Estimates on Rising Expenses
Acadia Healthcare Q1 Earnings Top Estimates on Rising Admissions
Adherex Technologies Inc. (FENC) Reports Q1 Loss, Tops Revenue Estimates
Other News for FENC
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC)
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC)
Fennec management to meet with Craig-Hallum
Fennec Pharmaceuticals Approves Proposals at Shareholder Meeting
Fennec Announces Results of Annual Meeting | FENC Stock News